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Total peripheral vascular resistance in pediatric renal
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Total peripheral vascular resistance in pediatric renal trans- cular reactivity include blood pressure (BP), cardiac out-
plant patients. put (CO), and total peripheral vascular resistance (TPR).
Background. Abnormal cardiovascular reactivity at rest and Knowledge of CO and TPR changes during exercise
during physical exercise may be a risk factor for left ventricular
may be helpful for understanding the effects of renalhypertrophy (LVH) in pediatric renal transplanted (Tx) pa-
disease upon exercise performance and possible end-tients. Data on total peripheral vascular resistance (TPR) are
not available. organ effects.
Methods. Eleven renal Tx patients treated with cyclosporine To our knowledge, data on TPR in pediatric renal
(7 females and 4 males; mean age 14.6  3.3 years; mean time transplant recipients are not available.
since transplantation 43  35 months) were evaluated for 24- The aim of the study was to evaluate CO and TPRhour blood pressure (BP), TPR and echocardiographic left
at rest and during exercise and left ventricular mass inventricular mass (LVM). TPR values of patients were com-
children and adolescents with renal transplantation.pared with data of a group of 11 healthy controls matched for
sex and age.
Results. Twenty-four–hour ambulatory blood pressure mon-
METHODSitoring showed that all but one patient had normal daytime
BP values and six patients showed a reduced or inverse noctur- Patients
nal dip. LVH was found in 72% of the patients. In comparison
Patients were enrolled according to the following crite-with healthy controls, patients showed significantly elevated
TPR at rest and during exercise suggesting an increased vascu- ria: transplantation performed at least six months prior
lar tone. The degree of LVH in these patients is severe and to the beginning of the study and glomerular filtration
appears disproportionate to the BP values. rate over 40 mL/min/1.73 m2. Absence of renal artery ste-
Conclusion. The high incidence of LVH can reflect an aug- nosis on Doppler examination, hyperparathyroidism, ormented cardiovascular reactivity associated with a disturbed
anemia defined as hemoglobin less than 110 g/L wascircadian pattern. The increase in TPR and the reduction of
requested.the nocturnal fall of BP also might contribute to the develop-
ment of LVH in young renal Tx patients. Controls were identified from a group of young healthy
subjects, not trained, who were examined for sport cer-
tification.
All patients and/or their families gave informed consent.In normal individuals a maximal exercise effort is
reached when the cardiovascular system has attained its
Cardiac outputmaximum capacity to deliver oxygenated blood to the
Cardiac output was evaluated by a mass spectrometerexercising muscles.
using an acetylene re-breathing technique. AlthoughAbnormal cardiovascular reactivity to challenging phys-
many techniques to measure CO have been described [1],ically stressful situations may be a risk factor for cardio-
the acetylene technique is well suited for measurement ofvascular disease and left ventricular hypertrophy (LVH)
CO in children at rest and during exercise [2].in renal transplant (Tx) patients. Measures of cardiovas-
This technique is based upon the assumption that inert
gases are transported in the blood in purely physical so-
lution. Transportation of most inert gases is blood flow-Key words: renal vascular resistance, children and transplantation, car-
diac hypertrophy, left ventricular hypertrophy, blood pressure. limited and the gas can be used to estimate cardiac output.
During the acetylene re-breathing maneuver the sub-Received for publication October 1, 2001
ject is asked to re-breathe the gas in a bag filled with aand in revised form June 18, 2002
Accepted for publication June 20, 2002 mixture of oxygen, acetylene and helium.
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Table 1. Twenty-four–hour ambulatory blood pressure monitoringthe relationships developed by Cander and Foster [3],
(ABPM), cardiovascular reactivity and echocardiographic
with modifications by Petrini, Peterson and Hyde [4]. results in renal transplant patients
Proper instrumentation such as a mass spectrometer
Mean SD Rangepermits the measurement of concentrations of gases rap-
SBP day mm Hg 114.311.3 94–135idly and accurately, and this method has been shown to
SBP night mm Hg 109.211 91–125
correlate well with both the invasive Fick method [5] DBP day mm Hg 67.68.4 54–80
DBP night mm Hg 647.5 55–77and the Doppler method of CO determination [6].
24-hour SBP mm Hg 11210.5 96–132
24-hour DBP mm Hg 66.97.5 56–79Total peripheral vascular resistance
Dip SBP % 4.197.46 10.6/13.3
Dip DBP % 5.138.9 10.8/19.7The concurrent determination of CO and mean BP
CO at rest L/min 4.451.08 3.01–6.78allows the derivation of TPR to blood flow [7]. TPR was
CO during exercise L/min 8.542.26 13.14–6.27
calculated by the equation, TPR (dyne sec  cm5)  TPR at rest dyne  s  cm5 1655357 1374–925
TPR during exercise dyne  s  cm5 938132 1097–690(MAP/CO)  80, where MBP is mean blood pressure
LVM/height2.7 g/m2.7 55.413.7 75.5–35.52(mm Hg) and CO is cardiac output (L/min).
Abbreviations are: SBP, systolic blood pressure; DBP, diastolic blood pres-
sure; CO, cardiac output; TPR, total peripheral resistance; LVM, left ventricularBlood pressure
mass.
Blood pressure during the test was measured by aus-
cultation and a mercury sphygmomanometer according
to the recommendation of the Task Force on Blood in
Left ventricular mass was estimated using the equa-Children [8] with appropriately sized cuffs. MBP was
tion reported by Devereux et al [14] and was indexedcalculated with the equation: mean arterial pressure
according to the allometric regression equation usingMAP  (SBP 2 DBP)/3, where MAP is mean arterial
height2.7 [15].pressure, SBP is systolic blood pressure and DBP is dia-
stolic blood pressure.
Statistical analysisAfter completion of the laboratory evaluation the pa-
Data are expressed as mean  SD.tients underwent ambulatory BP monitoring (Oscillome-
Statistical analysis was performed with unpaired t teststric Spacelab device) for 24 hours, with a measurement
and the multiple linear regression technique.obtained every 15 minutes during the day and every 30
minutes at night. Blood pressure values were compared
to normal values for height and sex from the data of
RESULTS
Soergel et al [9].
The results of the 24-hour ambulatory blood pressureMeasures of SBP, DBP and nocturnal dip were calcu-
monitoring (ABPM), cardiovascular reactivity, and echo-lated as the differences between average daytime minus
cardiographic evaluation are shown in Table 1.nighttime readings expressed as a percentage of the day-
time average.
PatientsA reduced nocturnal dip was defined as5.5% corre-
Eleven renal transplanted patients (7 females and 4sponding to the 5th percentile in healthy children and
males, with mean age of 14.6 3.3 years) were enrolled.adolescents [9].
Mean time on dialysis was 45  38 months and mean
Treadmill test time since transplantation was 43  35 months. Eighty
percent of the patients had been on peritoneal dialysisA symptom-limited exercise test was performed ac-
and had no arteriovenous fistula, and the remaining 20%cording to the Bruce protocol [10], which involves vari-
had a non-functioning fistula. All patients received pred-able speed and slope. Details of this method are reported
nisone (dosage 7.5 mg/m2/day) and cyclosporine (meanelsewhere [11]. The test was stopped when the patients
concentration 300 to 350 ng/mL  h). Mean cyclospo-could not continue despite strong verbal encouragement.
rine concentration was calculated by the mean AUC 
Left ventricular mass evaluation 195.8  (2.4  C2)  (7.7  C6), where AUC is area
under the curve, C2 is the concentration two hours afterLeft ventricular echocardiography was performed with
cyclosporine administration, and C6 is the concentrationa two-dimensional and M-mode ECHO by a standard
six hours after cyclosporine administration [16]. Seventechnique with subjects in a supine position [12].
patients were on antihypertensive treatment. All patientsMeasurements of internal left ventricular end-systolic
on antihypertensive treatment were taking a calciumand end-diastolic diameters, end-diastolic interventricu-
channel blocker, and two of them were taking an angio-lar septal thickness and end-diastolic posterior wall thick-
tensin-converting enzyme inhibitor. Only three of theness were made according to the American Society of
Echocardiography Criteria [13]. seven patients on antihypertensive treatment were hyper-
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Fig. 1. Daytime and nighttime (A) systolic and (B) diastolic blood
pressure profiles of the pediatric patients. Blood pressure is expressed
as the difference in mm Hg to the individual height and gender statistics
for the 95th percentiles of ambulatory day- or nighttime blood pressure [5].
Fig. 2. Cardiac output (CO; L/min) in renal transplanted patients (TX)
and controls at rest and during exercise. CO was found to be significantly
lower in patients in comparison to control subjects both at rest andtensive before transplantation. Eleven healthy untrained
during exercise.subjects (7 females and 4 males; mean age 13.1  1.8
years) being evaluated for sports certification were iden-
tified as the controls. They were matched for sex and
age (mean age of patients vs. mean age of controls, P 
NS). Weight and height of patients were similar in pa-
tients and healthy controls (51.2  8.3 vs. 52.4  11.2 kg
and 150  8.3 vs. 157  12 cm respectively, P  NS).
Blood pressure profiles
Daytime and nighttime SBP and DBP profiles of pa-
tients are reported in Figure 1. BP was expressed as the
difference in mm Hg from the individual’s values as
predicted from the height and sex 95th percentile of nor-
mal ambulatory daytime or nighttime BP values [9]. All
but one patient had normal daytime values.
One patient had a reduced and five patients had an
Fig. 3. Total peripheral vascular resistance (TPR) in renal transplantedinverse nocturnal dip, that is, nocturnal hypertension.
patients versus controls. In comparison with healthy controls, patientsThe mean nocturnal dip of SBP and DBP in patients showed resting TPR to significantly elevated at rest and during exercise.
was 4.19% (SD 7.46) and 5.13% (SD 8.9), respectively.
Cardiovascular reactivity
Left ventricular mass
The adaptive change in our patients in TPR and CO
The distribution of LVM index (LVMi) is shown induring exercise was preserved and the performance was
Figure 4. LVMi was compared to normal values pub-not significantly different in comparison with controls
lished by de Simone et al [15]. LVMi values of controls(duration 9.45  2.06 in patients vs. 11.13  2.52 min in
have not been reported because healthy subjects exam-controls, P  NS). Figure 2 shows data on CO for both
ined for sports certification are not requested for echo-patients and controls at rest and during exercise. CO
cardiographic evaluation. LVMi was above the normalwas significantly lower in patients in comparison with
range in 82% of patients. The possible determinants ofcontrols both at rest (4.45  1.08 vs. 6.25  0.95 L/min,
LVH in patients (weight, height, sex, age, duration of
P  0.001) and during exercise (8.54  2.26 vs. 11.75 
dialysis, TPR, BP, drugs) also were explored by a multi-
3.03 L/min, P  0.01). variate regression model analysis, but the data did not
In comparison with healthy controls, the patients showed converge after 20 iterations due to the insufficient sample
a resting TPR that was significantly elevated (1655  size [17].
357 vs. 1144  159 dyne  sec  cm5, P  0.0001).
This difference between the two groups remained dur-
DISCUSSIONing the exercise, suggesting a generalized, consistent in-
creased in vascular tone (938 132 vs. 693 166 dyne Left ventricular hypertrophy is found frequently after
renal transplantation in pediatric patients [18]. The de-sec  cm5, P  0.001; Fig. 3).
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increased vascular tone that can be evaluated by the
mean of TPR at rest and during acute laboratory stress
has been associated with increased LVM [30]. To our
knowledge, there are no reports assessing TPR in pediat-
ric renal transplanted patients at rest and during exercise.
In adult cardiac transplant recipients an increase in TPR
has been described in association with an attenuation of
the nocturnal fall in blood pressure [31]. The present
study examined the hemodynamic status of a group of
young patients with a renal transplant after a relatively
long period of transplantation. Hemodynamic evalua-
tions in our small cohort show that CO is significantlyFig. 4. Left ventricular mass (LVM) indexed for height2.7 (g/m2.7) in
renal transplanted patients in reference to de Simone normal values lower and TPR are significantly higher in patients in
for age and gender (horizontal line; A, females; B, males). The whiskers comparison with controls both at rest and during exer-denote the range of the 95th confidence interval [10].
cise. Normally CO increases with increasing exercise in-
tensity. According to the Frank Starling law, the primary
factor in controlling stroke volume and, consequently,
CO is the extent to which the ventricle stretches. Whengree of hypertrophy is often severe after renal trans-
plantation [19] as confirmed by our previous [20] and the ventricle stretches more it will contract with more
force. Another factor that can contribute to an increasepresent data. Mitsfenes et al, who studied changes in the
LVMi after renal transplantation, recently reported that in stroke volume at rest and during exercise is TPR.
During exercise, increasing vasodilation allows the leftLVH persists in children and adolescents after renal
transplantation [21]. This was not dependent on the type ventricle to contract against less resistance, facilitating
emptying of the blood from this chamber. This mecha-of dialysis, donor source, cause of renal failure, steroid
dose or cyclosporine. nism in our patients seems to be impaired with a conse-
quent augmented workload for the heart at rest andA number of factors have been advocated as possible
causes of LVH, such as hypertension [22], steroid ther- during exercise.
Cyclosporine administration has been implicated as aapy [23], cyclosporine use [24], and sympathetic overacti-
vity [25]. We cannot exclude a permissive or additive possible cause for increased TPR with consequent left
ventricular hypertrophy. A recent cross-sectional studyeffect of steroids on LVH development, but a clear rela-
tionship between steroids and cardiac hypertrophy is showed that the use of cyclosporine following transplan-
tation is accompanied by higher rates of LVH in compar-still lacking [26]. Our patients received a low dose of
prednisone therapy at the time of the study. They had a ison with azathioprine treatment [27]. They found an
inadequately controlled arterial hypertension and highernormal daytime BP pattern and an attenuated or inverse
nocturnal dipping. The degree of LVH in these patients rates for carotid plaque and increased intima-media
thickness in the cyclosporine group. Cyclosporine hasappears disproportionate if compared with the blood
pressure values. Left ventricular mass increase can only been indicated to induce an increase in systemic vascular
resistance, but the underlying mechanism is not clear.be partly explained by blood pressure anomalies. Gali-
atsou et al observed in a group of adults with renal Several mechanisms have been proposed, such as changes
in renal circulation [32], increased sympathetic nerve activ-transplantation that the increase in LVM index per SD
of BP was greater than that reported in general popula- ity [33], increased endothelin-1 mediated vasoconstriction
[34], and a decrease in the endothelial nitric oxide-depen-tion in the Framingham heart study [27, 28]. Since LVH
may develop despite apparent control of BP [20], it is dent vasodilation [35]. Nitric oxide produced in the endo-
thelium of arterioles is a potent vasodilator through itspossible that other mechanisms may be involved in the
development of LVH in these patients. Thus, the high action on smooth muscle cell relaxation. Its role during
exercise in humans has not been clearly established, butincidence of LVH can reflect, at least in part, a disturbed
BP circadian pattern. The exact mechanism influencing is likely to be important. This study was not designed to
investigate on these factors.the control of nighttime BP is not known. Cyclosporine
has been reported to affect blood pressure regulatory In conclusion, despite the limitations of a relatively
small number of patients, our results show that childrensystems, but the exact mechanism by which it might
influence the nighttime blood pressure pattern is not and adolescents with a renal transplant have significantly
increased TPR at rest and during exercise. The increaseknown. One possible mechanism may be an augmented
sympathetic activity, which would normally be reduced in TPR with the possible reduction of the nocturnal fall
of BP might contribute to the development of LVH inor absent during overnight sleep. This was reported in
cyclosporine-treated heart transplant recipients [29]. An these young renal transplanted patients.
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